NettetJonathan C. Trent, MD, PhD The symptoms of GIST can be somewhat vague and nonspecific, and there may be no symptoms early on because of submucosal localization and noninvasive behavior. Patients with GIST might initially be thought to have irritable bowel syndrome, anemia, gastric ulcers, gallbladder disease, or any number of … Nettet1. feb. 2011 · The NPI number assigned to Dr. Jonathan Magruder M.D. is 1427354810, registered as an "individual" on February 01, 2011 Where is Dr. Jonathan Magruder M.D. located? The provider is located at 242 King Avenue Suite 230 Athens, Ga 30606 and the phone number is (706) 475-1700 Which is Dr. Jonathan Magruder M.D. specialty?
ExpertPerspectives
Nettet19. nov. 2024 · Jonathan C. Trent, MD, PhD, professor and associate director for Clinical Research at the Sylvester Comprehensive Cancer Center, University of Miami Health … NettetJonathan C. Trent, MD, PhD I would like to see the concept of immunotherapy developed more broadly for patients with GIST, hoping that we can figure out some way to make more tumors sensitive to immune checkpoint inhibitors, whether that is with a combination with a KIT inhibitor or some other immunotherapy agent such as interferon, to further activate … meds that increase calcium levels
Jonathan C. Trent, MD, PhD - onclive.com
Nettet4. aug. 2024 · Jonathan C. Trent, MD, PhD, recently discussed the treatment considerations he makes when treating patients with gastrointestinal stromal tumors (GIST). Trent discussed his treatment decisions based on 2 case scenarios during a Targeted Oncology live case-based peer perspectives dinner. NettetMay 28th 2024. Jonathan C. Trent, MD, PhD, discusses Sylvester Comprehensive Cancer Center’s ongoing efforts to advance the precision medicine process to improve … Nettet21. apr. 2024 · Jonathan Trent, MD, PhD: Larotrectinib certainly is the first NRTK inhibitor that was studied. It has been studied in a number of studies, and researchers have looked at many subsets in this entity. meds that increase ammonia level